Back to Search
Start Over
Six-year duration of adjuvant imatinib in high-risk GIST: more to come.
- Source :
-
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2025 Mar; Vol. 36 (3), pp. 346-347. Date of Electronic Publication: 2024 Dec 02. - Publication Year :
- 2025
Details
- Language :
- English
- ISSN :
- 1569-8041
- Volume :
- 36
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Annals of oncology : official journal of the European Society for Medical Oncology
- Publication Type :
- Editorial & Opinion
- Accession number :
- 39631623
- Full Text :
- https://doi.org/10.1016/j.annonc.2024.11.013